English | Español

Community
+ Community
Patient Daily | Nov 13, 2025

Westerly Hospital receives top safety grade from The Leapfrog Group
+ Pharmaceuticals
Patient Daily | Nov 12, 2025

UTHealth Houston team credited with saving young girl through rare pediatric urology expertise
+ Pharmaceuticals
Patient Daily | Nov 11, 2025

Baylor College of Medicine appoints new advisors and board leadership
+ Pharmaceuticals
Patient Daily | Nov 10, 2025

Political commentator on 340B abuse: 'They're lining pockets, not helping patients'
+ Pharmaceuticals
Patient Daily | Nov 10, 2025

Rep. DeGraaf on 340B program: ‘340B providers statistically provide less unreimbursed care’
+ Pharmaceuticals
Patient Daily | Nov 10, 2025

Cherie Zachary named president of American College of Allergy, Asthma & Immunology
+ Pharmaceuticals
Patient Daily | Nov 9, 2025

UTHealth Houston receives Top Workplace honor from Houston Chronicle for 11th time
+ Community
Patient Daily | Nov 8, 2025

Understanding cookie-bite hearing loss: causes, diagnosis and management

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns